{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:24:49Z","timestamp":1743449089712,"version":"3.37.3"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T00:00:00Z","timestamp":1527724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Clin Oncol"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1038\/s41571-018-0049-4","type":"journal-article","created":{"date-parts":[[2018,5,31]],"date-time":"2018-05-31T08:05:20Z","timestamp":1527753920000},"page":"538-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Steps towards effective gynaecological cancer screening"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3708-1732","authenticated-orcid":false,"given":"Usha","family":"Menon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,31]]},"reference":[{"key":"49_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aap8793","volume":"10","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Evaluation of liquid from the papanicolaou test and other liquid biopsies for the detection of endometrial and ovarian cancers. Sci. Transl. Med. 10, eaap8793 (2018).","journal-title":"Sci. Transl. Med."},{"key":"49_CR2","doi-asserted-by":"publisher","first-page":"167ra4","DOI":"10.1126\/scitranslmed.3004952","volume":"5","author":"I Kinde","year":"2013","unstructured":"Kinde, I. et al. Evaluation of DNA from the papanicolaou test to detect ovarian and endometrial cancers. Sci. Transl. Med. 5, 167ra4 (2013).","journal-title":"Sci. Transl. Med"},{"unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program. Cancer stat facts: uterine cancer. NCI SEER \n                           \n                    https:\/\/seer.cancer.gov\/statfacts\/html\/corp.html\n                    \n                   (2018).","key":"49_CR3"},{"unstructured":"Cancer Research UK. Uterine cancer statistics. Cancer Research UK \n                    http:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/uterine-cancer\n                    \n                   (2018).","key":"49_CR4"},{"key":"49_CR5","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/S1470-2045(10)70268-0","volume":"12","author":"I Jacobs","year":"2011","unstructured":"Jacobs, I. et al. Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort. Lancet Oncol. 12, 38\u201348 (2011).","journal-title":"Lancet Oncol."},{"key":"49_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1000114","volume":"6","author":"PO Brown","year":"2009","unstructured":"Brown, P. O. & Palmer, C. The preclinical natural history of serous ovarian cancer: defining the target for early detection. PLoS Med. 6, e1000114 (2009).","journal-title":"PLoS Med."},{"key":"49_CR7","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/S0140-6736(15)01224-6","volume":"387","author":"IJ Jacobs","year":"2016","unstructured":"Jacobs, I. J. et al. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet 387, 945\u2013956 (2016).","journal-title":"Lancet"},{"key":"49_CR8","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1200\/JCO.2014.59.4945","volume":"33","author":"U Menon","year":"2015","unstructured":"Menon, U. et al. Risk algorithm using serial biomarker measurements doubles the number of screen-detected cancers compared with a single-threshold rule in the United Kingdom Collaborative Trial Of Ovarian Cancer Screening. J. Clin. Oncol. 33, 2062\u20132071 (2015).","journal-title":"J. Clin. Oncol."},{"key":"49_CR9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.ygyno.2014.01.018","volume":"132","author":"CB Powell","year":"2014","unstructured":"Powell, C. B. Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later. Gynecol. Oncol. 132, 261\u2013263 (2014).","journal-title":"Gynecol. Oncol."},{"key":"49_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1191-5","volume":"18","author":"S Kang","year":"2017","unstructured":"Kang, S. et al. CancerLocator: non-invasive cancer diagnosis and tissue-of-origin prediction using methylation profiles of cell-free DNA. Genome Biol. 18, 53 (2017).","journal-title":"Genome Biol."},{"key":"49_CR11","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejogrb.2015.12.008","volume":"197","author":"N Hanegem van","year":"2016","unstructured":"van Hanegem, N. et al. The accuracy of endometrial sampling in women with postmenopausal bleeding: a systematic review and meta-analysis. Eur. J. Obstet. Gynecol. Reprod. Biol. 197, 147\u2013155 (2016).","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."}],"container-title":["Nature Reviews Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41571-018-0049-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41571-018-0049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41571-018-0049-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T22:26:52Z","timestamp":1684621612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41571-018-0049-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,31]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["49"],"URL":"https:\/\/doi.org\/10.1038\/s41571-018-0049-4","relation":{},"ISSN":["1759-4774","1759-4782"],"issn-type":[{"type":"print","value":"1759-4774"},{"type":"electronic","value":"1759-4782"}],"subject":[],"published":{"date-parts":[[2018,5,31]]},"assertion":[{"value":"31 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"U.M. has stock ownership awarded by her employer (University College London) in and has received research funding from Abcodia Pvt Ltd, a company with an interest in screening and early detection of cancer.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}